Markets:

Overview

News

Currencies

International

Treasuries

Azitra Inc Common Stock (NY:AZTR)

0.2040 +0.0031 (+1.54%)

Streaming Delayed Price Updated: 2:06 PM EST, Feb 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Azitra Inc Common Stock

< Previous 1 2 3 4 5 Next >

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

April 24, 2025

Via Benzinga

On Thursday, there are stocks with unusual volume. Let's take a look. ↗

February 06, 2025

Let's explore the current happenings on the US markets on Thursday. Below, you'll find the stocks exhibiting unusual volume in today's session.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

February 05, 2025

Via Benzinga

Tuesday's session: most active stocks ↗

February 04, 2025

Let's have a look at what is happening on the US markets on Tuesday. Below you can find the most active stocks in today's session.

Via Chartmill

AZTR Stock Earnings: Anitra Reported Results for Q2 2024 ↗

August 12, 2024

Anitra just reported results for the second quarter of 2024.

Via InvestorPlace

Tuesday's session: top gainers and losers ↗

February 04, 2025

Keep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements.

Via Chartmill

Traders are paying attention to the gapping stocks in Tuesday's session. ↗

February 04, 2025

Let's have a look at the gap up and gap down stocks in today's session.

Via Chartmill

US Stocks Mixed; PepsiCo Posts Downbeat Sales ↗

February 04, 2025

Via Benzinga

Discover the top movers in Tuesday's pre-market session. ↗

February 04, 2025

Before the US market kicks off on Tuesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

February 04, 2025

Via Benzinga

Why Palantir Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket ↗

February 04, 2025

Via Benzinga

Friday's after hours session: top gainers and losers ↗

January 24, 2025

After the conclusion of the US market's regular session on Friday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.

Via Chartmill

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

January 23, 2025

Via Benzinga

Crude Oil Rises Sharply; JPMorgan Chase Earnings Top Views ↗

January 15, 2025

Via Benzinga

Nasdaq Surges Over 2%; Goldman Sachs Posts Upbeat Q4 Results ↗

January 15, 2025

Via Benzinga

Dow Jumps 600 Points; US Inflation Increases To 2.9% In December ↗

January 15, 2025

Via Benzinga

Topics Economy Stocks

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

January 15, 2025

Via Benzinga

Why Vision Marine Technologies Shares Are Trading Higher By 68%; Here Are 20 Stocks Moving Premarket ↗

January 15, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

January 14, 2025

Via Benzinga

Azitra to Present at BIO-Europe 2024

October 29, 2024

From Azitra, Inc.

Via Business Wire

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 24, 2024

Via Benzinga

Azitra to Participate in the 2024 Maxim Healthcare Virtual Summit

October 11, 2024

From Azitra, Inc.

Via Business Wire

Why Phoenix Motor Shares Are Trading Higher By 150%; Here Are 20 Stocks Moving Premarket ↗

October 04, 2024

Via Benzinga

Azitra, Inc. Announces Late-Breaking Presentation at the European Academy of Dermatology and Venereology Congress

September 24, 2024

From Azitra, Inc.

Via Business Wire

Azitra Receives Fast Track Designation for ATR-04 for Skin Rash from EGFR Inhibitors

September 18, 2024

From Azitra, Inc.

Via Business Wire

Azitra to Present at the H.C. Wainwright 26th Annual Global Investment Conference

September 06, 2024

From Azitra, Inc.

Via Business Wire

Azitra Announces First Patient Dosed in Phase 1b Trial of ATR-12 for Netherton Syndrome

August 28, 2024

From Azitra, Inc.

Via Business Wire

Azitra Receives Study May Proceed letter from the FDA for IND to Treat Skin Rash from EGFR Inhibitors

August 22, 2024

From Azitra, Inc.

Via Business Wire

Why Keysight Technologies Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket ↗

August 21, 2024

Via Benzinga

Azitra Announces First Patient Screened and Scheduled to Enroll in Phase 1b Trial of ATR-12 for Netherton Syndrome

August 20, 2024

From Azitra, Inc.

Via Business Wire

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.